The following data is part of a premarket notification filed by Carmel Pharma Ab. with the FDA for Phaseal.
| Device ID | K023747 |
| 510k Number | K023747 |
| Device Name: | PHASEAL |
| Classification | Set, I.v. Fluid Transfer |
| Applicant | CARMEL PHARMA AB. BOX 5352 Gothenburg, SE 40228 |
| Contact | Kjell Andreasson |
| Correspondent | Kjell Andreasson CARMEL PHARMA AB. BOX 5352 Gothenburg, SE 40228 |
| Product Code | LHI |
| CFR Regulation Number | 880.5440 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Special |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2002-11-08 |
| Decision Date | 2002-11-15 |
| Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PHASEAL 75322844 2471820 Live/Registered |
Carmel Pharma AB 1997-07-11 |